Polyclonal Antibody to Ubiquitin Carboxyl Terminal Hydrolase L1 (UCHL1) Homo sapiens (Human) Polyclonal antibody

PARK5; PGP9.5; Uch-L1; Neuron cytoplasmic protein 9.5; Ubiquitin thioesterase L1; Ubiquitin carboxyl-terminal hydrolase isozyme L1

  • Polyclonal Antibody to Ubiquitin Carboxyl Terminal Hydrolase L1 (UCHL1) Packages (Simulation)
  • Polyclonal Antibody to Ubiquitin Carboxyl Terminal Hydrolase L1 (UCHL1) Packages (Simulation)
  • Polyclonal Antibody to Ubiquitin Carboxyl Terminal Hydrolase L1 (UCHL1) Figure. DAB staining on IHC-P; Samples: Human Kidney Tissue.
  • Polyclonal Antibody to Ubiquitin Carboxyl Terminal Hydrolase L1 (UCHL1) Figure:FITC staining on IHC-P
    Simple: A549 cells
  • Polyclonal Antibody to Ubiquitin Carboxyl Terminal Hydrolase L1 (UCHL1) Figure. DAB staining on IHC-P;
    Samples: Human Glioma Tissue.
  • Polyclonal Antibody to Ubiquitin Carboxyl Terminal Hydrolase L1 (UCHL1) Figure. DAB staining on IHC-P;
    Samples: Human Brain Tissue.
  • Polyclonal Antibody to Ubiquitin Carboxyl Terminal Hydrolase L1 (UCHL1) Figure. DAB staining on IHC-P;
    Samples: Human Lung Cancer Tissue.
  • PAG945Hu01.jpg Figure. Western Blot; Sample: Recombinant UCHL1, Human.
  • Polyclonal Antibody to Ubiquitin Carboxyl Terminal Hydrolase L1 (UCHL1) Figure. Western Blot; Sample: Lane1: Mouse Brain Tissue; Lane2: Porcine Brain Tissue; Lane3: Human U-87MG Cells; Lane4: Human A549 Cells.
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

SPECIFITY

The antibody is a rabbit polyclonal antibody raised against UCHL1. It has been selected for its ability to recognize UCHL1 in immunohistochemical staining and western blotting.

USAGE

Western blotting: 0.5-5µg/mL
Immunocytochemistry in formalin fixed cells: 5-20µg/mL
Immunohistochemistry in formalin fixed frozen section: 5-20µg/mL
Immunohistochemistry in paraffin section: 5-20µg/mL
Optimal working dilutions must be determined by end user.

STORAGE

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for one year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Reference

  • J Neurol SciChanges of ubiquitin C-terminal hydrolase-L1 levels in serum and urine of patients with white matter lesionsPubMed: 26232084
  • Journal of the Neurological SciencesIncreased plasma UCH-L1 after aneurysmal subarachnoid hemorrhage is associated with unfavorable neurological outcomePubmed:26810533